Development of a High-Throughput Assay for Inhibitors of the Polo-Box Domain of Polo-Like Kinase 1 Based on Time-Resolved Fluorescence Energy Transfer-Reference-Cited by-同舟云学术

Development of a High-Throughput Assay for Inhibitors of the Polo-Box Domain of Polo-Like Kinase 1 Based on Time-Resolved Fluorescence Energy Transfer

Published:2017 Issue:9 Volume:40 Page:1454-1462
ISSN:0918-6158
Container-title:Biological & Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Kim Tae Gi¹²,Lee Ju Hee¹,Lee Mi Young¹,Kim Ka-Ul¹³,Lee Jeong Hyun¹³,Park Chi Hoon¹³,Lee Byung Ho¹²,Oh Kwang-Seok¹³

Affiliation:

1. Bio-Organic Science Division, Korea Research Institute of Chemical Technology

2. Graduate School of New Drug Discovery and Development, Chungnam National University

3. Department of Medicinal and Pharmaceutical Chemistry, University of Science and Technology

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/40/9/40_b17-00283/_pdf

Reference33 articles.

1. 1) Barr FA, Silljé HH, Nigg EA. Polo-like kinases and the orchestration of cell division. Nat. Rev. Mol. Cell Biol., 5, 429–441 (2004).

2. 2) van de Weerdt BC, Medema RH. Polo-like kinases: a team in control of the division. Cell Cycle, 5, 853–864 (2006).

3. 3) Strebhardt K, Ullrich A. Targeting polo-like kinase 1 for cancer therapy. Nat. Rev. Cancer, 6, 321–330 (2006).

4. 4) Xie S, Xie B, Lee MY, Dai W. Regulation of cell cycle checkpoints by polo-like kinases. Oncogene, 24, 277–286 (2005).

5. 5) Takai N, Hamanaka R, Yoshimatsu J, Miyakawa I. Polo-like kinases (Plks) and cancer. Oncogene, 24, 287–291 (2005).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of a Fluorescence Recovery-Based Polo-Like Kinase 1 Binding Assay to Polo-Like Kinase 2 and Polo-Like Kinase 3;Biological and Pharmaceutical Bulletin;2024-07-11

2. A concise synthesis of carbasugars isolated from Streptomyces lincolnensis;Tetrahedron;2020-12

3. Identification of a New Heterocyclic Scaffold for Inhibitors of the Polo-Box Domain of Polo-like Kinase 1;Journal of Medicinal Chemistry;2020-11-11

4. DITMD-induced mitotic defects and apoptosis in tumor cells by blocking the polo-box domain-dependent functions of polo-like kinase 1;European Journal of Pharmacology;2019-03